Syndicated Research Report Hospital & Healthcare Infrastructure

Hospitals And Outpatient Care Centers Market

Size, Share & Industry Analysis, By Type (Hospitals, Outpatient Care Centers), By Expenditure Type (Public Expenditure, Private Expenditure), By Facility Type (General Medical & Surgical Hospitals, Ambulatory Surgery Centers, Dialysis Centers, Urgent Care Centers, Imaging & Diagnostic Centers, Specialty Clinics), By Clinical Service Line (Acute & Emergency Care, Elective Surgery & Procedures, Chronic Disease Management, Diagnostic & Specialist Consultations), and Regional Forecast, 2026-2034

Report ID 24LS-15643
Pages 74
Last Updated
Author 24LifeSciences Research Team
Industry Hospital & Healthcare Infrastructure
Starting from $995 USD

Market Overview

2025 Market SizeUSD 6420.0 BnBase year
2026 EstimateUSD 6766.7 BnEstimated year
2034 ForecastUSD 10306.2 BnForecast value
CAGR5.4%2026–2034
Largest RegionNorth America2025

Hospitals and Outpatient Care Centers Market Overview

The global Hospitals and Outpatient Care Centers Market generated an estimated USD 6,420.0 billion in 2025 from hospital and ambulatory patient-care services. The 2026 estimate is USD 6,766.7 billion, with revenue projected to reach USD 10,306.2 billion in 2034 at a 5.4% CAGR.

39%Hospital-provider share of OECD health spending in 2023OECD 2025
25%Ambulatory-provider share of OECD health spendingOECD 2025
USD 1.63TUS hospital spending in 2024CMS
4.6 billionPeople lacking essential-service coverage in 2023WHO 2025

Patient-care revenue arises when hospitals, ambulatory surgery centers, dialysis clinics, urgent care facilities and specialist outpatient providers treat patients. Inpatient admissions, emergency encounters, outpatient procedures, consultations and related facility-based diagnostics are counted at the point of service. Standalone pharmacy retail, nursing-home residence, healthcare administration, medical-device sales and unrelated insurance premiums are excluded. Hospital-owned outpatient departments remain in the hospital type, avoiding duplicate allocation to freestanding centers.

The World Health Organization reported USD 9.8 trillion in global health spending for 2022. An extrapolated 2025 spending base of USD 10.7 trillion, combined with a 60% provider-service allocation informed by OECD expenditure accounts, produces the 2025 market estimate. The 60% share is a global modeling assumption rather than an audited worldwide provider total. OECD 2025 statistics put hospitals at 39% and ambulatory providers near one quarter of health spending across member countries.

In the United States, CMS measured USD 1,634.7 billion of hospital expenditure in 2024 and USD 1,109.7 billion for physician and clinical services. Its 2025–2034 projections call for annual growth of 5.2% in hospitals and 5.5% in physician and clinical services. These distinct categories support a 5.4% service-sector growth assumption, while payer changes and differences in national health-account definitions create uncertainty outside the US.

Hospital operators are expanding day-case and outpatient capacity while managing staffing costs. HCA Healthcare recorded USD 75.6 billion of 2025 revenue and same-facility fourth-quarter equivalent admissions growth of 2.5%. Tenet reported 520 ambulatory surgery centers and 25 surgical hospitals in its USPI network at March 2025. WHO estimated in December 2025 that 4.6 billion people lacked essential-service coverage in 2023, indicating unmet demand that depends on financing and trained clinicians.

Source: WHO health expenditure database; OECD provider spending; CMS national health expenditure.

Key Takeaways: Hospitals and Outpatient Care Centers Market

  • Base-year market size: Patient-care services in hospitals and ambulatory facilities represented an estimated USD 6,420.0 billion in 2025.
  • Forecast and CAGR: Worldwide provider-service revenue is forecast at USD 10,306.2 billion in 2034, equivalent to 5.4% annual growth from 2026.
  • Leading type: Hospitals represented an estimated ~68% of 2025 revenue, including inpatient and hospital-owned outpatient departments.
  • Leading expenditure type: Public Expenditure supported an estimated ~56% of 2025 provider-service revenue, including tax-funded and social-insurance payments.
  • Largest region: North America generated an estimated ~41% of 2025 revenue, reflecting US hospital prices and clinical service spending.
  • Key growth drivers: Population ageing, complex chronic disease, elective backlog reduction, ambulatory substitution, diagnostic access and facility investment support demand.
  • Competitive landscape: HCA, UHS, Tenet, Ramsay, IHH, Apollo, Fresenius Medical Care and DaVita operate different acute, elective and outpatient service models.
  • Report coverage: Forecasts cover Type, Expenditure Type, Facility Type and Clinical Service Line across five global regions through 2034.

Report Scope & Market Segmentation

Hospital and outpatient care provider revenue includes reimbursed and self-paid clinical encounters, allocated once to the delivering facility. The model uses a provider-based definition rather than summing overlapping inpatient and outpatient function accounts.

Report AttributeCoverage
Base Year2025
Estimated Year2026
Forecast Period2026–2034
Market MeasurementRevenue, USD million/billion
By TypeHospitals; Outpatient Care Centers
By Expenditure TypePublic Expenditure; Private Expenditure
By Facility TypeGeneral Medical & Surgical Hospitals; Ambulatory Surgery Centers; Dialysis Centers; Urgent Care Centers; Imaging & Diagnostic Centers; Specialty Clinics
By Clinical Service LineAcute & Emergency Care; Elective Surgery & Procedures; Chronic Disease Management; Diagnostic & Specialist Consultations
By RegionNorth America; Europe; Asia-Pacific; Latin America; Middle East & Africa
Selected CountriesUnited States; Canada; United Kingdom; Germany; Japan; India; China; Brazil; Mexico; Saudi Arabia
Key Market PlayersHCA Healthcare, Inc.; Universal Health Services, Inc.; Tenet Healthcare Corporation; Fresenius Medical Care AG; DaVita Inc.; Ramsay Health Care Limited; IHH Healthcare Berhad; Apollo Hospitals Enterprise Limited; Fortis Healthcare Limited; Spire Healthcare Group plc; Acibadem Healthcare Group; Surgery Partners, Inc.

Market Definition & Revenue Boundaries

Included revenue is the provider payment for patient-facing acute admissions, elective operations, ambulatory consultations, renal dialysis, urgent care, hospital-based imaging and diagnostics. For a patient receiving surgery in a hospital outpatient department, the episode is assigned to Hospitals rather than to Outpatient Care Centers. A freestanding surgical facility is assigned to the outpatient type. The Facility Type and Clinical Service Line axes classify the same revenue independently, so totals are never summed across axes.

The market model applies method B to WHO global expenditure evidence: USD 9.8 trillion in 2022 is extended to a 2025 parent of USD 10.7 trillion using nominal spending growth, and 60% is allocated to in-scope providers. OECD 2023 provider shares provide the structural reference, while US CMS spending projections provide the 5.4% growth assumption. These modeled values are not consolidated audited revenues of all hospitals worldwide.

Hospitals and Outpatient Care Centers Market Dynamics

Drivers Impact Analysis*

Market DriversImpact RankCAGR Contribution (%)2026–20282029–20312032–2034
Population ageing and rising chronic disease encounter frequencyHigh+2.10%HighHighHigh
Elective backlog clearance and diagnostic access expansionHigh+1.70%HighMediumMedium
Ambulatory surgery migration and faster care pathwaysMedium-High+1.30%HighHighHigh
Government hospital infrastructure and health coverage investmentMedium+1.10%MediumHighHigh
Digital scheduling and clinical workflow productivityLow-Medium+0.80%MediumMediumHigh
Others (renal dialysis demand, specialty clinics, oncology pathways)Low+0.50%MediumMediumMedium

Restraints Impact Analysis*

Market RestraintsImpact RankCAGR Contribution (%)2026–20282029–20312032–2034
Workforce shortages and wage inflation restricting staffed capacityHigh-0.90%HighHighMedium
Public tariff ceilings and payer utilization controlsMedium-High-0.70%HighMediumMedium
Capital costs and delayed facility commissioningMedium-0.30%MediumMediumLow
Others (payment arrears, rural access gaps, uncompensated care)Low-0.20%MediumMediumMedium

*CAGR contribution shows the percentage points each factor adds to or removes from the 5.4% CAGR for 2026–2034; driver contributions less restraint contributions equal the market CAGR. Period columns rate the strength of each factor in that window.

Ageing and multimorbidity increase encounter intensity

OECD Health at a Glance 2025 documented major differences in hospital capacity, with Japan and Korea holding 12–13 beds per 1,000 people compared with a 4.2 OECD average. Older patients often require repeated cardiology, oncology, renal and orthopedic care rather than a single isolated visit. Fresenius Medical Care served 291,902 dialysis patients in 2025, illustrating the recurring-treatment nature of chronic disease. Facilities with multidisciplinary services can retain more follow-up care, while constrained workforces limit their ability to convert clinical need into billable appointments.

Elective surgery backlogs drive new clinical capacity

NHS England published an elective reform plan in January 2025 targeting the 18-week referral-to-treatment standard by March 2029. It supports additional diagnostic access and better patient scheduling rather than relying solely on traditional overnight admission. In the United States, CMS finalized a 2.6% 2026 payment update for eligible hospital outpatient departments and ambulatory surgery centers. These measures can increase treated volumes, but reimbursement constraints prevent an equal rise in revenue per episode. Theatre availability, anesthesia staffing and recovery beds determine how quickly providers convert waiting lists into completed procedures.

Payer rate updates determine provider yield

CMS projected US hospital spending growth of 5.2% annually during 2025–2034, below the broader rise in national health spending. Its 2026 outpatient rule added price-transparency requirements and revised reporting for ambulatory surgery centers. USPI recorded 6.8% same-facility net patient service revenue growth in the first quarter of 2025 even as surgical case counts fell 2.1%, showing that case mix and pricing can offset volume weakness. Government budgets and private insurer contracts therefore influence revenue growth independently of admissions and visit counts.

Staffing shortages constrain bed and clinic utilization

WHO and OECD data show that workforce availability varies sharply between high-income and emerging healthcare systems. OECD reported just over nine nurses per 1,000 people on average in 2023, but Mexico and T - rkiye had about three or fewer. A licensed bed cannot generate inpatient revenue when a hospital lacks trained nurses, technicians or anesthetists. Providers must fund recruitment, retention and productivity systems before expanding surgical lists. Labour inflation can reduce operating margins even where patient demand and reimbursement grow, making staffing a direct restraint on facility expansion.

Public funding gaps delay access in lower-income regions

The WHO 2025 universal coverage report estimated that 2.1 billion people faced financial hardship from out-of-pocket health spending in 2022. In markets with limited insurance, hospitals may face low occupancy despite substantial unmet clinical need because patients defer diagnostics and planned procedures. Brazil is using the Agora Tem Especialistas programme to mobilize private hospitals for publicly funded procedures, while Saudi Arabia is expanding regional service coverage. Public purchasing contracts can unlock additional visits, although payment delays and lower tariffs restrict the rate at which new clinical capacity becomes financially sustainable.

Sources: OECD Health at a Glance 2025; CMS NHE and 2026 OPPS; NHS England; WHO UHC 2025; Tenet USPI; Fresenius Medical Care.

Hospitals and Outpatient Care Centers Market Segmentation by Type

Report Segmentation
By Type

Provider revenue is allocated to Hospitals or Outpatient Care Centers according to the entity delivering the encounter. Hospital-owned outpatient departments remain in Hospitals, while independent clinics and freestanding surgical facilities enter the outpatient category. This allocation follows the OECD provider classification rather than treating every same-day visit as independent ambulatory revenue.

Largest Provider Type

Hospitals

Hospitals represented an estimated ~68% of 2025 revenue. They collect inpatient, emergency, intensive-care and hospital outpatient payments and handle high-acuity services requiring operating theatres or multidisciplinary teams. CMS reported USD 1.63 trillion of US hospital expenditure in 2024, while OECD provider accounts assigned 39% of health spending to hospitals in 2023. The category includes both public and private hospitals; admission mix, length of stay and payer contracts determine realized revenue.

Expanding Provider Type

Outpatient Care Centers

Outpatient Care Centers represented the remainder of the modeled provider split, encompassing independent surgery centers, dialysis units, urgent care and specialist facilities. Tenet USPI held interests in 520 ambulatory surgery centers in March 2025, and Fresenius Medical Care operated 3,601 dialysis clinics worldwide at year-end 2025. Growth benefits from shorter recovery times, standardized protocols and insurer incentives for lower-cost settings. Freestanding facilities remain limited by the complexity of cases they can safely treat.

Hospitals retain the larger revenue base because complex emergency, critical-care and inpatient procedures cannot be fully substituted by freestanding sites. Outpatient centers gain procedural volumes as clinical guidelines, reimbursement and anesthesia capabilities expand same-day eligibility.

Hospitals and Outpatient Care Centers Market Segmentation by Expenditure Type

Report Segmentation
By Expenditure Type

Public Expenditure and Private Expenditure classify the ultimate financing source of each patient-care payment, not the ownership of the treating facility. A private hospital paid by a government scheme enters the public financing category, while self-pay treatment in a public hospital is allocated to private expenditure. This distinction prevents ownership and payer mix from being combined in one dimension.

Largest Funding Source

Public Expenditure

Public Expenditure represented an estimated ~56% of 2025 provider-service revenue. Tax-funded systems, social insurance, Medicare, Medicaid and public purchasing programmes finance major shares of hospital activity in Europe, North America and parts of Asia. CMS reported Medicare spending of USD 1.118 trillion and Medicaid spending of USD 931.7 billion in 2024 across healthcare categories. Public tariffs can support high patient throughput but may limit reimbursement growth when budgets tighten.

Commercial and Household Funding

Private Expenditure

Private Expenditure includes employer-sponsored and individual insurance reimbursements, direct household payments and philanthropic funding. CMS measured USD 1.645 trillion in US private insurance spending and USD 556.6 billion out of pocket in 2024 across healthcare. Private-pay specialty centers can invest in convenient scheduling and differentiated accommodation, while insurers negotiate procedure bundles and steer eligible patients to ambulatory sites. High deductibles and coverage exclusions may delay nonurgent care in employer-sponsored plans and self-pay facilities.

Government coverage expansion can shift patients from private out-of-pocket payment toward public purchasing without changing the physical provider. Forecasts should therefore separate payer redistribution from genuine growth in treated episodes.

Hospitals and Outpatient Care Centers Market Segmentation by Facility Type

Report Segmentation
By Facility Type

Facility Type distinguishes principal care settings rather than mixing the ownership or reimbursement model. Each provider is classified by its primary clinical function: acute hospital, ambulatory surgery, dialysis, urgent care, imaging and diagnostics, or specialist clinic. Hospital-operated units are consolidated under General Medical & Surgical Hospitals to avoid counting internal departments twice.

Acute-Care Infrastructure

General Medical & Surgical Hospitals

General Medical & Surgical Hospitals form the largest facility category because emergency departments, inpatient wards and operating rooms support high-value, complex episodes. UHS recorded more than 347,700 acute-care inpatient admissions and 1.7 million emergency visits during 2025. Operating leverage depends on staffed-bed utilization, procedure mix and local payer contracts. Capital requirements and 24-hour coverage costs make this category less flexible than small ambulatory clinics.

Scheduled Procedures

Ambulatory Surgery Centers

Ambulatory Surgery Centers focus on elective interventions with predictable recovery, allowing higher operating-room turnover and lower overnight staffing needs. The CMS 2026 outpatient rule broadened eligible procedures and updated ASC payment rates by 2.6%. USPI reported USD 1.194 billion in first-quarter 2025 ambulatory net operating revenue. Other facility types serve recurring dialysis, urgent episodes, diagnostics and specialist consultations, each with distinct visit frequency and staffing requirements.

Dialysis centers earn repeat treatment fees, imaging centers depend on scanner throughput and referrals, urgent care facilities manage episodic walk-in demand, and specialty clinics monetize consultation and procedure bundles. These operating models require separate unit-economics assumptions for visit frequency, equipment utilization and reimbursed tariffs.

Hospitals and Outpatient Care Centers Market Segmentation by Clinical Service Line

Report Segmentation
By Clinical Service Line

Clinical Service Line attributes each billed encounter to its dominant medical purpose: acute and emergency treatment, elective procedures, chronic disease management, or diagnostics and specialist consultations. An emergency admission later requiring imaging remains in acute care when the hospital bills one bundled episode. Separately billed outpatient imaging performed in freestanding diagnostic centers is classified as diagnostics rather than acute care.

Acute and Emergency Services

Acute & Emergency Care

Acute & Emergency Care accounts for the largest service-line revenue pool because intensive care, trauma, urgent admissions and emergency departments require continuous clinical coverage. UHS disclosed 1.7 million emergency visits in 2025, while CMS measured USD 1.635 trillion in total US hospital spending for 2024. Complexity, severity and treatment duration influence revenue per case more than appointment volume alone.

Scheduled Treatment

Elective Surgery & Procedures

Elective Surgery & Procedures benefits from recovery of deferred care and shorter length of stay. NHS England’s January 2025 plan seeks to restore the 18-week referral-to-treatment standard by March 2029. USPI’s 2025 ambulatory portfolio illustrates growing dedicated day-surgery capacity. Chronic Disease Management covers recurring dialysis and specialist follow-up, while Diagnostic & Specialist Consultations captures standalone imaging, testing and physician evaluation.

Service-line mix changes as patients move from emergency stabilization to planned follow-up and as payers steer low-acuity operations into outpatient settings. Provider accounting must assign bundled episodes once even when several clinical departments contribute to treatment.

Hospitals and Outpatient Care Centers Market Regional Analysis

Geographic demand reflects patient-service spending, financing coverage, facility density, labor supply and the proportion of clinical activity delivered through hospitals versus freestanding centers. Five regions are modeled on a 2025 revenue basis; only the largest regional share is published.

North America

Largest region - ~41% of 2025 provider revenue

North America represented an estimated ~41% of global 2025 provider revenue, reflecting high US reimbursement levels and extensive hospital and ambulatory networks. CMS recorded USD 5.3 trillion of national health expenditure in 2024, including USD 1.635 trillion of hospital care. The region is shifting eligible procedures to outpatient settings while health systems invest in cancer centers, cardiovascular programmes and digitally coordinated specialty clinics. Staffing shortages and insurer utilization reviews restrict throughput despite growing clinical demand. Canada maintains a more publicly financed service model, with hospital budgets and provincial capacity planning influencing elective access.

Priority country signals

United States

Selected market signal

CMS projects 5.2% average annual hospital expenditure growth over 2025–2034, while physician and clinical services grow 5.5%. The 2026 outpatient final rule updates eligible hospital and ASC payments by 2.6% and adds price transparency obligations. HCA reported USD 75.6 billion in 2025 revenue and 2.5% same-facility equivalent admission growth in the fourth quarter, showing how provider volume and payer yield shape receipts.

Source: CMS.

Canada

Selected market signal

OECD 2025 data place Canada among countries spending less than 30% of health budgets through hospital providers, reflecting a different delivery mix from the OECD average. Provincial plans finance most medically necessary hospital and physician care, while access to scheduled procedures depends on available clinicians and theatre time. Outpatient substitution can ease bed demand but requires coordinated referrals and diagnostic capacity.

Source: OECD.

Europe

Public-payer intensive - Elective recovery and ageing

Europe has extensive publicly financed hospital networks and growing pressure to reduce waiting lists without proportional increases in staffed beds. Eurostat reported EUR 1.72 trillion of EU health expenditure in 2023, equal to 10.0% of GDP. OECD 2025 data show that hospital-provider shares vary substantially, with countries using different balances of inpatient wards, day surgery and specialist ambulatory care. Wage inflation and public tariff limits constrain margins for both independent providers and state systems. Expansion increasingly targets diagnostic hubs, community-based consultations and shorter-stay elective procedures rather than large general hospitals alone.

Priority country signals

United Kingdom

Selected market signal

NHS England published its elective reform plan on 6 January 2025, setting out a route toward the 18-week referral-to-treatment standard by March 2029. The policy encourages direct diagnostic access, digital scheduling and more consistent use of community services. Independent providers may receive additional NHS-funded elective volumes, but workforce availability and contractual payment rates govern how much new capacity can be delivered.

Source: NHS England.

Germany

Selected market signal

Eurostat measured EUR 492 billion in German health expenditure for 2023, the largest national total within the EU. Hospital and ambulatory providers face different reimbursement and planning arrangements, while ageing patients raise demand for complex chronic care. The OECD reported that some European systems retain inpatient-heavy service patterns, making day-case substitution and care coordination important determinants of future facility utilization.

Source: Eurostat.

Asia-Pacific

Capacity investment - Urban specialist expansion

Asia-Pacific combines high-capacity systems in Japan and Korea with lower bed density and substantial unmet need in emerging markets. OECD 2025 statistics put Japan and Korea at 12–13 hospital beds per 1,000 people, far above the OECD average. Private hospital operators are investing in India, Singapore, Malaysia and China, often emphasizing oncology, cardiac services and day-care pathways. Japan faces high spending pressure from population ageing, while Indian demand depends on insurer networks and affordability. Regional growth is supported by specialist expansion but restrained by clinical staffing, unequal rural access and varying public reimbursement and different patterns of hospital referral.

Priority country signals

India

Selected market signal

Apollo Hospitals reported 8,025 operating beds and 7.3 million outpatient visits in fiscal 2025. Its annual report also recorded 604,000 discharges and a 68% occupancy rate, indicating significant throughput across hospital and clinic settings. New urban specialty capacity can serve insured patients, but staffing and commissioning requirements delay full revenue realization in newly opened facilities.

Source: Apollo Hospitals.

Japan

Selected market signal

OECD 2025 indicators show Japan among the highest hospital-bed-density systems, with 12–13 beds per 1,000 people. High capacity does not eliminate pressures from an ageing population and a shrinking clinical workforce. Care planning increasingly favors efficient hospital discharge, outpatient follow-up and coordinated long-term disease management to limit unnecessary inpatient stays.

Source: OECD.

Latin America

Coverage development - Mixed public-private delivery

Latin America combines large publicly funded networks with private hospitals serving insured and self-paying patients. Brazil is expanding specialist access through a 2025 programme that mobilizes private hospitals for public-sector surgical and diagnostic work. Mexico has a large ambulatory provider sector: OECD 2025 data place it among countries where about one-third of health spending flows to ambulatory providers. Uneven specialist distribution and payment affordability constrain utilization outside major cities. Providers able to coordinate referrals and negotiate predictable public contracts may expand volumes without replicating high-cost acute infrastructure in every community.

Priority country signals

Brazil

Selected market signal

The Brazilian Ministry of Health reports that its Agora Tem Especialistas initiative converts R$150 million of liabilities into additional SUS services delivered by 28 private hospitals. More than 150 proposals were approved to expand access during 2026. These arrangements use existing operating rooms and diagnostic infrastructure, but public reimbursement and patient transport still affect effective treatment capacity.

Source: Brazil Ministry of Health.

Mexico

Selected market signal

OECD 2025 provider accounts identify Mexico among systems with high relative ambulatory spending and hospital-provider funding below 30% of total health expenditure. General practitioners, specialty offices and outpatient centers absorb a substantial share of routine care. Public insurance eligibility, regional workforce differences and patient travel costs influence whether diagnostic referrals progress to specialist treatment.

Source: OECD.

Middle East & Africa

Infrastructure gaps - Public coverage expansion

Middle Eastern governments are expanding hospital infrastructure and public purchasing of private-sector services, while many African health systems face shortages of trained clinicians and financial protection. Saudi Arabia reported 97.5% basic health-service coverage of populated areas by the end of 2025 under its health transformation programme. WHO estimated 4.6 billion people worldwide lacked essential-service coverage in 2023, a challenge disproportionately affecting low-resource settings. New hospitals need sustainable payment systems, supply chains and workforce training before physical capacity becomes regular patient throughput. Regional demand can rise with insurance expansion, but private out-of-pocket exposure remains a restraint.

Priority country signals

Saudi Arabia

Selected market signal

The Saudi Ministry of Health stated in June 2026 that its 2025 transformation programme reached 97.5% coverage of populated areas with basic health services. Government plans emphasize integrated care and better access beyond major urban centers. Private operators can participate in hospital and clinic capacity expansion, but regulated tariffs and clinical recruitment determine the financial return from new sites.

Source: Saudi Ministry of Health.

Sub-Saharan Africa

Selected market signal

WHO and World Bank monitoring published in December 2025 found 2.1 billion people worldwide experienced financial hardship from health spending in 2022. In lower-income African markets, limited insurance protection can suppress clinic attendance and delay hospital admission. Investments in workforce, referral transport and essential diagnostics are needed alongside new buildings to raise utilization and reduce avoidable emergency care.

Source: WHO.

Competitive Landscape

Hospitals and outpatient centers compete through local referral networks, clinical outcomes, payer contracts and geographic coverage. HCA Healthcare reported USD 75.6 billion of 2025 revenue, while Universal Health Services generated USD 17.4 billion across acute and behavioral care. These consolidated corporate totals contain business mixes that differ from the narrowly defined provider-service market. Large systems invest in specialty capabilities and outpatient affiliates; independent centers compete on appointment availability, case selection and unit costs.

Integrated Acute Networks

HCA Healthcare and UHS

HCA reported 2025 revenue of USD 75.6 billion and UHS disclosed 5.8 million patient encounters. Emergency departments, inpatient beds and affiliated clinics support cross-referrals, but staffing and payer rates determine profit per episode.

Ambulatory Surgery Scale

Tenet USPI and Surgery Partners

USPI held interests in 520 surgery centers and 25 surgical hospitals at March 2025. Same-day case selection and payer contracting underpin the economics of freestanding elective surgery networks.

Recurring Renal Services

Fresenius Medical Care and DaVita

Fresenius Medical Care treated 291,902 patients across 3,601 dialysis centers in 2025. Renal providers face repeated reimbursement decisions and rising demand from chronic kidney disease.

International Specialty Systems

IHH, Ramsay, Apollo and Fortis

Apollo reported 7.3 million outpatient visits in fiscal 2025, while IHH added ambulatory care centers in Singapore, Hong Kong and Shanghai. International operators pursue specialty demand across diverse national payment regimes.

Contracting advantages differ between acute hospitals, freestanding surgical facilities and recurring renal treatment networks. Hospitals need emergency readiness, intensive care, specialized staff and broad clinical accreditation; surgery centers can focus on predictable elective procedures with lower overnight overhead. The 2026 CMS payment updates and transparency obligations affect both groups but do not equalize the costs of treating complex patients. Quality metrics and readmission rates increasingly shape referral decisions by payers and large employers.

Expansion strategies reflect population density, insurance coverage and clinical recruitment conditions in each geography. Apollo is increasing specialist capacity in India, IHH is developing ambulatory sites across Asian cities, and Fresenius Medical Care is optimizing its dialysis network rather than maximizing clinic count. Public hospitals remain central in many countries but are not always represented by listed corporate competitors. Private-sector financial statements therefore cannot be summed to derive the entire worldwide provider market, particularly where government-owned facilities dominate.

Price and case-mix changes complicate revenue comparisons between hospital operators and ambulatory surgery partnerships. Tenet reported first-quarter 2025 USPI net operating revenue of USD 1.194 billion, but consolidated surgery center revenue differs from system-wide net patient revenue that includes unconsolidated ventures. UHS reported USD 1 billion invested in equipment and facility expansion during 2025. Operators with access to capital can adopt advanced imaging and surgical techniques, while rural providers may need public support to sustain essential emergency coverage.

Key Companies Profiled

  • HCA Healthcare, Inc.
  • Universal Health Services, Inc.
  • Tenet Healthcare Corporation
  • Fresenius Medical Care AG
  • DaVita Inc.
  • Ramsay Health Care Limited
  • IHH Healthcare Berhad
  • Apollo Hospitals Enterprise Limited
  • Fortis Healthcare Limited
  • Spire Healthcare Group plc
  • Acibadem Healthcare Group
  • Surgery Partners, Inc.

Recent Developments in the Hospitals and Outpatient Care Centers Market

January 2025 — NHS elective reform plan: NHS England published a programme to restore the 18-week referral-to-treatment standard by March 2029. The measures include more diagnostic access and better digital patient pathways, with implications for independent elective capacity, outpatient appointments and hospital operating-room utilization and may change the timing of specialist referrals across regional health systems. Source

March 2025 — USPI ambulatory network expands: Tenet reported interests in 520 ambulatory surgery centers and 25 surgical hospitals as of March 31, 2025. First-quarter ambulatory revenue reached USD 1.194 billion, while system-wide same-facility surgical cases declined 2.1%, demonstrating the importance of case mix and payer rates as insurers negotiate lower-cost locations for appropriate elective procedures. Source

November 2025 — CMS finalizes 2026 outpatient rates: CMS issued the 2026 hospital outpatient and ambulatory surgery center final rule on November 21, 2025. It established 2.6% rate updates for qualifying facilities and introduced expanded price transparency data requirements, affecting reimbursement and administrative costs for US providers and the documentation needed to support accurate public comparison of negotiated service prices. Source

December 2025 — WHO releases universal coverage monitoring: WHO published its 2025 global monitoring report on December 5, finding 4.6 billion people lacked essential-service coverage in 2023. The report highlights financing barriers that limit hospital and clinic utilization, even when infrastructure is available, and the need for better financial protection when outpatient visits generate substantial household costs. Source

January 2026 — HCA reports 2025 service growth: HCA Healthcare announced USD 75.6 billion of 2025 revenue on January 27, 2026, up from USD 70.6 billion in 2024. Fourth-quarter same-facility equivalent admissions grew 2.5%, supporting the importance of patient throughput and clinical intensity to integrated hospital economics even when surgical volumes differ between inpatient and outpatient departments. Source

April 2026 — UHS publishes annual operating metrics: Universal Health Services released its 2025 annual report on April 9, 2026. The company disclosed 5.8 million patient encounters and USD 17.4 billion in revenue, alongside USD 1 billion of facility and equipment investment, documenting capacity spending across acute and ambulatory settings as patient pathways require coordinated staffing, diagnostics and treatment capacity. Source

Market Outlook, 2026–2034

The Hospitals and Outpatient Care Centers Market is projected to rise from USD 6,766.7 billion in 2026 to USD 10,306.2 billion in 2034. The 5.4% annual trajectory reflects CMS provider spending forecasts applied to a modeled worldwide care-services base, with facility investment and reimbursement policy shaping the path.

Forecast variable2025–2026 evidenceExpected 2034 influence
Ageing and chronic diseaseOECD 2025 capacity and demographic indicatorsMore repeated specialist visits and higher-acuity episodes
Ambulatory substitutionCMS 2026 outpatient payment policyMore eligible same-day procedures and reduced bed-days
Public financingWHO 2025 UHC monitoringHigher demand where coverage expands; tariff pressure remains
Staffed clinical capacityOECD nurse and hospital-bed dataLimits conversion of physical infrastructure into services
Provider consolidationHCA, UHS, Tenet and IHH disclosuresLarger networks but local competition and payer scrutiny

North American revenue should remain concentrated in hospitals with strong emergency, oncology and cardiovascular capabilities, while outpatient surgery centers gain share in suitable elective procedures. CMS expects US hospital spending to grow 5.2% annually and physician and clinical services 5.5% through 2034. The global model uses 5.4% as an evidence-based benchmark, not as a guaranteed rate for every country. Changes in insurance enrollment and public budgets could create periods of weaker utilization.

European health systems face pressure to reduce waiting lists while limiting long hospital stays. NHS England’s March 2029 elective target encourages day-care models and community diagnostics, whereas Eurostat recorded EUR 1.72 trillion of EU health expenditure in 2023. Providers that can maintain quality while reducing avoidable bed days may improve throughput without proportional construction costs. Workforce shortages and fiscal ceilings could delay planned expansion of hospital theatres and community diagnostic hubs.

Asia-Pacific offers capacity additions in urban India, China and Southeast Asia alongside high existing bed density in Japan and Korea. Apollo’s 2025 operating metrics show how specialist throughput can expand within established hospitals, while IHH’s ambulatory investments target lower-acuity care outside traditional inpatient campuses. Growth in patient visits will depend on insurance access, clinician recruitment and the time needed to commission new facilities. Currency fluctuations may alter dollar-denominated regional revenue independently of local procedure volumes.

Latin American and Middle Eastern providers may benefit from public purchasing of private-sector services, as illustrated by Brazil’s Agora Tem Especialistas initiative and Saudi Arabia’s health transformation programme. However, WHO estimates that billions still lack effective service coverage or face financial hardship from care costs. In such settings, added hospital beds alone cannot create sustainable demand. The forecast remains sensitive to government payment reliability, clinical workforce supply, rural access and capital costs.

Report Coverage

Coverage includes the revenue earned by patient-care facilities and clinical service providers, without separately adding the same episodes under their financing and clinical classification.

Global revenue model2025 base, 2026 estimate, 2034 forecast and eight-year CAGR.
Provider typesHospitals and freestanding outpatient care centers with consolidated departments counted once.
Expenditure channelsPublic and private payment sources allocated by the ultimate payer.
Facility categoriesSix principal provider settings, from acute hospitals to dialysis and imaging clinics.
Clinical servicesEmergency, elective, chronic and diagnostic patient-care activities.
Regional comparisonFive regions with evidence from national accounts, payers and operators.

Frequently Asked Questions

How large is the Hospitals and Outpatient Care Centers Market?

The market is estimated at USD 6,420.0 billion in 2025 and USD 6,766.7 billion in 2026, reaching USD 10,306.2 billion in 2034. This is a modeled provider-service total derived from WHO expenditure and OECD provider shares, not a consolidated audit of every hospital.

What CAGR is forecast for hospitals and outpatient care centers?

The forecast uses 5.4% annual growth during 2026–2034. CMS projects 5.2% growth in US hospital spending and 5.5% for physician and clinical services over 2025–2034, providing a relevant benchmark, while other regions face different public financing and exchange-rate conditions.

Which region leads the Hospitals and Outpatient Care Centers Market?

North America holds an estimated 41% of 2025 provider-service revenue. US hospital expenditure reached USD 1.635 trillion in 2024, and physician and clinical services exceeded USD 1.1 trillion, reflecting comparatively high payment rates and extensive hospital and ambulatory networks.

What is included in outpatient care center revenue?

The category includes freestanding ambulatory surgery, dialysis, urgent care, imaging, diagnostic and specialty-clinic patient services. Hospital-owned outpatient departments are assigned to hospitals to prevent duplicate revenue. Standalone pharmacy retail, insurance premiums and unrelated medical-device sales fall outside the defined provider market.

Are outpatient surgery centers cheaper than hospitals?

Many eligible same-day procedures can be delivered at lower facility cost in ambulatory surgery centers because they require less overnight staffing and bed infrastructure. CMS expanded its 2026 ASC procedure list, but savings depend on patient selection, payer rates, procedure complexity and postoperative care requirements.

What are the largest provider companies in this market?

HCA Healthcare, Universal Health Services, Tenet USPI, Fresenius Medical Care, DaVita, Ramsay, IHH and Apollo operate major clinical networks. Their footprints differ by hospital, surgery, dialysis and specialist care, so total corporate revenue should not be equated with directly comparable patient-service sales.

How do public and private expenditures differ?

Public expenditure includes tax-financed and social-insurance payments even when private hospitals deliver the treatment. Private expenditure includes commercial insurance and direct household payment for reimbursed and self-financed clinical encounters. CMS reported USD 1.118 trillion in Medicare and USD 931.7 billion in Medicaid spending in 2024 across healthcare categories.

Why are dialysis centers included in outpatient care?

Dialysis clinics deliver recurring supervised treatments for kidney failure without requiring a conventional hospital admission for each session. Fresenius Medical Care operated 3,601 dialysis clinics globally at the end of 2025, illustrating the scale of dedicated outpatient chronic-disease infrastructure.

How will hospital staffing shortages affect market growth?

Shortages of nurses, anesthetists and technicians restrict the number of staffed beds and operating sessions available. OECD data show major workforce differences between countries. Providers may face wage inflation and delays opening new facilities even when insurance coverage and patient demand support additional appointments.

What will shape hospital and outpatient markets through 2034?

Population ageing, chronic disease, elective waiting-list clearance, reimbursement and clinical workforce capacity will shape provider revenue. NHS England targets 18-week elective access by March 2029, while US Medicare updates outpatient payment rules annually; financing and safety standards will determine which settings gain activity.

Research Sources & Evidence Base

View research sources used for this overview
  1. WHO. Global Health Expenditure Database, December 2025.
  2. WHO. Global health expenditure report and documentation, 2025.
  3. OECD. Health at a Glance 2025: Expenditure by provider, November 2025.
  4. OECD. Health at a Glance 2025: Expenditure by type of service, November 2025.
  5. CMS. National Health Expenditure Fact Sheet, 2026.
  6. CMS. 2026 Hospital OPPS and ASC Final Rule, November 2025.
  7. NHS England. Elective care reform plan and targets, January 2025.
  8. Eurostat. EU healthcare expenditure 2023, November 2025.
  9. WHO. Tracking Universal Health Coverage 2025, December 2025.
  10. HCA Healthcare. Fourth-quarter and FY2025 results, January 2026.
  11. Tenet Healthcare. First-quarter 2025 ambulatory network results, April 2025.
  12. Universal Health Services. 2025 annual report announcement, April 2026.
  13. Fresenius Medical Care. 2025 annual results of operations, March 2026.
  14. Fresenius Medical Care. 2025 annual report patient statistics, March 2026.
  15. Apollo Hospitals. Annual Report 2024–25, August 2025.
  16. Brazil Ministry of Health. Agora Tem Especialistas 2025 results, 2025.
  17. Saudi Ministry of Health. Health sector transformation report 2025, June 2026.
  18. Brazil Ministry of Health. Basic health unit electronic records census, June 2025.
  19. OECD. Health at a Glance 2025 full report, November 2025.
  20. Fresenius Medical Care. 2025 Form 20-F clinical service and network figures, March 2026.
Trusted collaboration

Supporting teams across the life-sciences ecosystem

Focused market intelligence for commercial, strategy, product, and research teams across healthcare and life sciences.

Bain
Deloitte
PwC
Commercial Healthcare Partners
Client logo
Client logo
Life-sciences market focus Clear scope and sample review Confidential enquiry support

Display logos only where use is approved. A logo does not imply a public endorsement.

Client feedback

What teams value in their research experience

Feedback from research engagements, with client identities omitted where confidentiality applies.

Publish named testimonials only when the individual and organization have approved disclosure.

Research transparency

Built on a clearly defined research framework

Review the report scope, forecast timeframe, methodology, and cited evidence before deciding whether the full study fits your requirement.

Defined Market Scope

Coverage, segmentation, geography, and market boundaries are stated within the report.

Evidence-Led Overview

Readers can review the published sources and evidence referenced in this market overview.

Forecast Context

Base, estimated, and forecast years are shown to place the market outlook in context.

Current Publication Record

Each overview displays its report identifier and latest update date.

Report ID 24LS-15643
Base Year 2025
Forecast Period 2025–2034
Last Updated 29 Oct 2026
Inside the full report

What you can explore in this market report

A structured view of market size, forecast outlook, segmentation, regional dynamics, competitive activity, and the research framework behind this study.

01

Market Sizing & Forecasts

Review the market estimate, growth outlook, forecast direction, and key factors influencing future demand.

02

Segmentation Analysis

Understand the report’s defined segments, demand drivers, applications, end users, and market opportunities.

03

Regional Market View

Assess regional performance, selected country context, and factors shaping adoption across major markets.

04

Competition & Developments

Explore company profiles, market positioning, and selected developments relevant to the market landscape.

05

Market Dynamics & Trends

Review key demand drivers, challenges, emerging opportunities, technology shifts, and factors influencing market direction.

06

Research Methodology & Sources

Understand the report scope, market boundaries, research approach, and evidence referenced in the published market overview.